Your browser doesn't support javascript.
loading
Higher intraindividual variability of body mass index is associated with elevated risk of COVID-19 related hospitalization and post-COVID conditions.
Yu, Elaine A; Bravo, Marjorie D; Avelino-Silva, Vivian I; Bruhn, Roberta L; Busch, Michael P; Custer, Brian.
Affiliation
  • Yu EA; Vitalant Research Institute, San Francisco, CA, USA. EYu@vitalant.org.
  • Bravo MD; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA. EYu@vitalant.org.
  • Avelino-Silva VI; Vitalant, Scottsdale, AZ, USA.
  • Bruhn RL; Vitalant Research Institute, San Francisco, CA, USA.
  • Busch MP; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
  • Custer B; Vitalant Research Institute, San Francisco, CA, USA.
Int J Obes (Lond) ; 2024 Aug 12.
Article in En | MEDLINE | ID: mdl-39134693
ABSTRACT

BACKGROUND:

Cardiometabolic diseases are risk factors for COVID-19 severity. The extent that cardiometabolic health represents a modifiable factor to mitigate the short- and long-term consequences from SARS-CoV-2 remains unclear. Our objective was to evaluate the associations between intraindividual variability of cardiometabolic health indicators and COVID-19 related hospitalizations and post-COVID conditions (PCC) among a relatively healthy population.

METHODS:

This retrospective, multi-site cohort study was a post-hoc analysis among individuals with cardiometabolic health data collected during routine blood donation visits in 24 US states (2009-2018) and who responded to COVID-19 questionnaires (2021-2023). Intraindividual variability of blood pressure (systolic, diastolic), total circulating cholesterol, and body mass index (BMI) were defined as the coefficient of variation (CV) across all available donation timepoints (ranging from 3 to 74); participants were categorized into CV quartiles. Associations were evaluated by multivariable binomial regressions.

RESULTS:

Overall, 3344 participants provided 42,090 donations (median 9 [IQR 5, 17]). The median age was 48 years (38, 56) at the first study donation. 1.2% (N = 40) were hospitalized due to COVID-19 and 15.5% (N = 519) had PCC. Higher BMI variability was associated with greater risk of COVID-19 hospitalization (4th quartile aRR 4.15 [95% CI 1.31, 13.11], p = 0.02; 3rd quartile aRR 3.41 [95% CI 1.09, 10.69], p = 0.04). Participants with higher variability of BMI had greater risk of PCC (4th quartile aRR 1.29 [95% CI 1.02, 1.64]; p = 0.04). Intraindividual variability of blood pressure (systolic, diastolic) and total circulating cholesterol were not associated with COVID-19 hospitalization or PCC risk (all p > 0.05). From causal mediation analysis, the association between the highest quartiles of BMI variability and PCC was not mediated by hospitalization (p > 0.05).

CONCLUSIONS:

Higher intraindividual variability of BMI was associated with COVID-19 hospitalization and PCC risk. Our findings underscore the need for further elucidating mechanisms that explain these associations and importance for consistent maintenance of body weight.

Full text: 1 Database: MEDLINE Language: En Journal: Int J Obes (Lond) Journal subject: METABOLISMO Year: 2024 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Language: En Journal: Int J Obes (Lond) Journal subject: METABOLISMO Year: 2024 Type: Article Affiliation country: United States